SBI Securities’s Oragenics OGEN Stock Holding History

SBI Securities’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9	Sell	18 -5	-22%	-$3	﹤0.01%	4015
2026 Q2	$13	Buy	23 +12	+109%	+$7	﹤0.01%	3902
2026 Q1	$6	Buy	11 +1	+10%	+$1	﹤0.01%	3902
2025 Q4	$8	Hold	10	–	–	﹤0.01%	3895
2025 Q3	$13	Hold	10	–	–	﹤0.01%	3992
2025 Q2	$38	Buy	10 +9	+900%	+$46	﹤0.01%	3781
2025 Q1	$6	Hold	1	–	–	﹤0.01%	4018
2024 Q4	$11	Buy	+1	New	+$10	﹤0.01%	3924

Other funds holding OGEN

25 LLC St. Louis, Missouri $367M AUM 10.52% 1-Year Est. Return

SBI Securities's OGEN Position: Q3 2026 in Review

SBI Securities reduced its Oragenics (OGEN) stake by 22% in Q3 2026, selling an estimated $3 and leaving 18 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #4015.

SBI Securities first reported a position in OGEN in Q4 2024 and has held it in 8 quarters since. The position peaked at $38 in Q2 2025. 3 funds tracked by Wall St. Rank hold OGEN as of Q3 2026.

SBI Securities held 18 shares of Oragenics worth $9 as of Q3 2026.
SBI Securities sold 5 Oragenics shares in Q3 2026, an estimated $3.
Oragenics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #4015 holding.
SBI Securities first reported a position in Oragenics in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Oragenics position peaked at $38 in Q2 2025.
3 funds tracked by Wall St. Rank held Oragenics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.